Bottom line
Is LTMTX a good fund? The bottom line
LTMTX is the R3 share class of MFS Lifetime 2045 Fund, a managed target-date mutual fund from MFS.
It charges 0.79% — about $79 a year on every $10,000 invested, more expensive than 71% of target-date funds we track.
It returned +15.4% over one year, +8.9% a year over five years, +10.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $551 million in net assets and 28 holdings, its largest position is MFS Blended Research International Equity Fund (9.9%) and the top 10 make up 58.1% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (0.79%)
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What LTMTX invests in
The funds investment objective is to seek a high level of total return consistent with its asset allocation until the approximate retirement year in the fund's name; thereafter, the fund will seek total return through a combination of current income and capital appreciation. The asset allocation of the fund will change over time.
The fund is designed to provide diversification among different asset classes for investors with the approximate retirement year in the fund's name. MFS (Massachusetts Financial Services Company, the fund's investment adviser) invests substantially all of the fund's assets in other MFS mutual funds, referred to as underlying funds. MFS selects the asset class allocations based on a strategic asset allocation process that takes into account a variety of factors, including historical risk and performance, projected performance, and other factors. MFS analyses of projected performance are primarily based on quantitative models using various inputs such as valuation metrics, growth rates, profitability, yields, and inflation. MFS may also consider current market conditions, its qualitative assessment of the risk/return characteristics of asset classes, and other factors in determining…
From the fund's prospectus (filed Aug 27, 2026).
LTMTX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| LTMTX | +15.4% | +8.9% | +10.2% |
| Target-Date median | +15.7% | +8.2% | +8.9% |
Source: Fund prospectus, as of Dec 31, 2025
What LTMTX costs
On a $10,000 investment, LTMTX's 0.79% expense ratio costs about $79 a year. The prospectus estimates $1,195 in total costs over 10 years (assuming 5% annual returns). The median target-date fund charges 0.59%.
LTMTX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | MFS Blended Research International Equity Fund | 9.92% |
| 2 | MFS Blended Research Mid Cap Equity Fund | 9.39% |
| 3 | MFS Value Fund | 5.21% |
| 4 | MFS Blended Research Value Equity Fund | 5.20% |
| 5 | MFS Growth Fund | 4.84% |
| 6 | MFS Blended Research Growth Equity Fund | 4.83% |
| 7 | MFS Mid Cap Growth Fund | 4.69% |
| 8 | MFS Global Real Estate Fund | 4.69% |
| 9 | MFS Research Fund | 4.67% |
| 10 | MFS Blended Research Core Equity Fund | 4.67% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 58.1% of the fund. See all top 25 holdings and asset mix →